Ribavirin Therapy

Ribavirin Therapy is a pharmacological treatment modality within antiviral regimens that specifically employs the nucleoside analog ribavirin to inhibit viral replication, particularly in the management of select forms of acute viral hepatitis, distinguished by its immunomodulatory and direct antiviral mechanisms.

3.7K

Publications

251.7K

Citations

17.4K

Authors

3.8K

Institutions

Publications per year

2017–2026

347

Variants

Ribavirin Treatment

Authors

17.4K

  1. JG
    John G. McHutchison

    Gilead Sciences (United States), United States

    101 publications · 29.5K citations

    55

    h-index

  2. MS
    Mark Sulkowski

    Johns Hopkins University, United States

    76 publications · 15K citations

    41

    h-index

  3. SZ
    Stefan Zeuzem

    Goethe University Frankfurt, Germany

    73 publications · 11K citations

    40

    h-index

  4. EL
    Eric Lawitz

    Texas Liver Institute, United States

    54 publications · 13.1K citations

    37

    h-index

  5. ML
    Mitchell L. Shiffman

    Virginia Commonwealth University Medical Center, United States

    51 publications · 25.3K citations

    37

    h-index

1–5 of 17.4K

Venues

  1. Hepatology

    193 publications · 23.3K citations

    87

    h-index

  2. Journal of Hepatology

    260 publications · 14.1K citations

    63

    h-index

  3. Gastroenterology

    83 publications · 15.5K citations

    59

    h-index

  4. Antimicrobial Agents and Chemotherapy

    AAC · 115 publications · 6.4K citations

    50

    h-index

  5. Clinical Infectious Diseases

    CID · 74 publications · 6.6K citations

    45

    h-index

1–5